semaglutide eye disease linked to higher risk of vision problems, FDA data analysis shows Rybelsus Vision Loss Lawsuit [2026

This article explores the use of Rybelsus in patients without a gallbladder, covering efficacy, side effects, dosing, and monitoring requirements

Perampanel confirms to be effective and well-tolerated as an add-on treatment in patients with brain tumor-related epilepsy (PERADET Study)

Use caution in a patient with a history of angioedema or anaphylaxis with another GLP-1 receptor agonist Acute Gallbladder Disease: Acute events of gallbladder disease such as cholelithiasis or cholecystitis have been reported in GLP-1 receptor agonist trials and postmarketing

Semaglutide Tablets are taken once a day, ideally in the morning

Unlike some competitors that focus solely on GLP-1 medications, Levity provides a range of treatment options, including compounded semaglutide with glycine and B12, Mounjaro (tirzepatide), and Ozempic (semaglutide)